Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Beijing
Clinical trial register · China

Clinical Trials in Beijing, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 19187 matching records held by the registry are in this view. Synced 08 Nov 2026, 03:17 UTC
19187
Studies in scope
all four open statuses
11790
Recruiting now
open to new participants
2028
Lead sponsors
across recruiting studies
Top sites
Beijing 5576 Shanghai 3879 Guangzhou 3345 Hangzhou 1819 Wuhan 1343
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Peking Union Medical College Hospital271 Beijing Tiantan Hospital219 Cancer Institute and Hospital, Chinese Academy of Medical Sciences205 AstraZeneca191 Peking University People's Hospital166
Site location
Beijing5576 Shanghai3879 Guangzhou3345 Hangzhou1819 Wuhan1343
All 625 locations
Target enrolment
to

Trials with a site in Beijing

5576 of 19187 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Recruiting
Identification and Molecular Characterisation of Urban-environmental Stress Patterns Affecting Mental Illness
NCT07571226Major Depressive Disorder (MDD), Anxiety Disorder, Alcohol Use Disorder (AUD)
Huashan Hospital
Observational
680
Beijing, Shanghai
2026-04-10
By invitation
Shanghai United Cell Biotechnology Co., Ltd
Phase 4
6,000
Hefei, Beijing, Wuhan, Nanjing, Jinan
2026-04-10
Recruiting
Beijing Mabworks Biotech Co., Ltd.
Phase 3
316
Beijing
2026-04-10
Not yet open
Effect of tNGS on CAP Patients With Initial Treatment Failure
NCT07472114Community Acquired Pneumonia (CAP)
Capital Medical University
Not applicable
524
Beijing
2026-04-10
Not yet open
Gan & Lee Pharmaceuticals.
Phase 2
345
Beijing
2026-04-10
Recruiting
magAssist, Inc.
Not applicable
204
Beijing, Changsha, Guangzhou, Nanchang, Shanghai, Shenyang, Suzhou, Xi'an
2026-04-09
Recruiting
Tegileridine for Postoperative Pain After Adolescent Scoliosis Surgery
NCT07229495Scoliosis; Adolescence, Pain After Surgery, Analgesia, Patient-controlled
DrugsTegileridine·Morphine
Peking Union Medical College Hospital
Phase 4
171
Zhengzhou, Nanchang, Beijing, Shanghai
2026-04-08
Recruiting
Lepu Biopharma Co., Ltd.
Phase 1/2
160
Beijing, Fuzhou, Zhengzhou, Nanjing, Tianjin, Lishui
2026-04-08
Recruiting
Beijing Tiantan Hospital
Phase 2
159
Beijing, Luoyang, Panlong, Puyang, Linyi, Weifang
2026-04-08
Recruiting
Circunited BioPharma (Shenzhen) Co., Ltd.
Early Phase 1
5
Beijing
2026-04-07
Recruiting
Haisco Pharmaceutical Group Co., Ltd.
Phase 3
370
Huangshan City, Wuhu, Beijing, Zhanjiang, Changsha, Changchun, Linyi, Shanghai
2026-04-07
Recruiting
Efficacy of Pregabalin for Patients With Irritable Bowel Syndrome
NCT07635394Irritable Bowel Syndrome (IBS)
Beijing Tiantan Hospital
Not applicable
258
Beijing
2026-04-07
Recruiting
Gan & Lee Pharmaceuticals.
Phase 3
350
Beijing
2026-04-07
Recruiting
Intranasal Dexmedetomidine-esketamine Administration and Postoperative Pain in Pediatric Patients
NCT07479602Adenotonsillectomy, Children, Intranasal Administration, Dexmedetomidine
Peking University First Hospital
Phase 4
160
Beijing
2026-04-07
Recruiting
Dexamethasone Palmitate for Postoperative Pain
NCT07341854Pain, Postoperative, Dexamethasone Palmitate
DrugsDexamethasone palmitate·Dexamethasone
Beijing Tiantan Hospital
Not applicable
446
Beijing
2026-04-06
Recruiting
Guangdong Hengrui Pharmaceutical Co., Ltd
Phase 2
248
Beijing, Shanghai
2026-04-03
Recruiting
RemeGen Co., Ltd.
Phase 3
574
Hefei, Beijing, Chongqing, Fuzhou, Xiamen, Lanzhou, Dongguan, Guangzhou
2026-04-03
Recruiting
Peking Union Medical College Hospital
Early Phase 1
24
Beijing
2026-04-03
Recruiting
Duan Minghui
Not applicable
30
Beijing
2026-04-02
Recruiting
Grid eXplore Mapping Study
NCT07421076Paroxysmal Atrial Fibrillation (PAF)
Abbott Medical Devices
Not applicable
200
Jinan, Chengdu, Hangzhou, Ningbo, Beijing
2026-04-02
Recruiting
Beijing Tiantan Hospital
Phase 3
1,192
Beijing, Chongqing, Guangzhou, Baoding, Zhangjiakou, Zunhua, Mengzhou, Nanle
2026-04-02
Recruiting
Phase 3 Extension Study of ADX-324 in Participants With Hereditary Angioedema (HAE)
NCT07428499Hereditary Angioedema (HAE), Hereditary Angioedema - Type 1, Hereditary Angioedema - Type 2, HAE
ADARx Pharmaceuticals, Inc.
Phase 3
90
Beijing, Harbin, Zhengzhou
2026-04-02
Recruiting
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 2
33
Beijing, Chongqing, Guangdong, Harbin, Zhengzhou, Wuhan, Changsha, Changchun
2026-04-02
Not yet open
CAR19BCMA CAR-T Cells for the Treatment of R/R Plasma Cell Neoplasms and Lymphomas/Leukemias With Plasmacytic Differentiation
NCT06986434Relapsed or Refractory Plasma Cell Neoplasms, Lymphomas/Leukemias With Plasmacytic Differentiation
DrugFludarabine and cyclophosphamide
Affiliated Hospital to Academy of Military Medical Sciences
Early Phase 1
20
Beijing
2026-04-02
Recruiting
Beijing Tongren Hospital
Phase 2
43
Beijing
2026-04-01
Active, closed
Beijing Anzhen Hospital
Not applicable
224
Beijing
2026-04-01
Not yet open
Omitting Nasogastric Tube Decompression in Minimally Invasive Pancreaticoduodenectomy
NCT07370116Pancreaticoduodenectomy, Nasogastric Tube Decompression, Minimally Invasive Surgical Procedures
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 2
200
Beijing
2026-04-01
Not yet open
Beijing Anzhen Hospital
Phase 3
160
Beijing
2026-04-01
Recruiting
Liping Dou
Phase 2
30
Beijing
2026-04-01
Recruiting
Beijing Tongren Hospital
Phase 1/2
25
Beijing
2026-04-01
Recruiting
Peking University
Not applicable
500
Beijing
2026-04-01
Recruiting
68Ga-B7-H3 Nanobody ImmunoPET in Osteosarcoma
NCT07774533Osteosarcoma, Osteosarcoma, Recurrent, Refractory
Peking University First Hospital
Early Phase 1
16
Beijing
2026-04-01
By invitation
Peking University People's Hospital
Phase 2
40
Beijing
2026-04-01
Not yet open
Chen Miao
Not applicable
216
Beijing
2026-04-01
Not yet open
Peking Union Medical College Hospital
Phase 2
28
Beijing
2026-04-01
Not yet open
Feng Gao
Not applicable
286
Beijing
2026-04-01
Not yet open
Chinese SLE Treatment And Research Group
Phase 4
180
Beijing, Guanzhou, Shenzhen, Nanning, Jiaozuo, Luoyang, Wuhan, Nanjing
2026-04-01
Active, closed
IBI306 Monotherapy in Non-Familial Hypercholesterolemia and Mixed Hyperlipidemia
NCT07473960Non-Familial Hypercholesterolemia and Mixed Hyperlipidemia
DrugTafolecimab
Innovent Biologics (Suzhou) Co. Ltd.
Phase 3
198
Beijing
2026-04-01
Recruiting
Changchun GeneScience Pharmaceutical Co., Ltd.
Phase 1
186
Beijing
2026-04-01
Not yet open
Integrated Rehabilitation in HDU for Post-Intensive Care SyndromeLiberation in Patients With PICS
NCT07521540Post-Intensive Care Syndrome (PICS), Critical Illness Recovery, Mechanical Ventilation
Hongying Jiang, MD
Not applicable
250
Beijing
2026-04-01
Not yet open
Peking University People's Hospital
Not applicable
60
Beijing
2026-04-01
Recruiting
Beijing Chao Yang Hospital
Observational
2,800
Beijing
2026-04-01
Recruiting
AstraZeneca
Phase 2
60
Beijing, Changchun, Changsha, Chengdu, Foshan, Fuzhou, Guangzhou, Harbin
2026-04-01
Not yet open
yilong Wang
Not applicable
86
Beijing, Kaifeng, Xinxiang, Zhengzhou, Linyi, Tianjin
2026-04-01
Recruiting
Beijing Boren Hospital
Early Phase 1
2
Beijing, Shanghai
2026-04-01
Not yet open
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 2
60
Beijing
2026-04-01
Not yet open
Multimodal Kidney-Sparing Strategy for High-Risk Upper Tract Urothelial Carcinoma
NCT07504939Upper Tract Urothelial Carcinoma Receiving Kidney-sparing Therapy, Upper Tract Urothelial Carcinoma
Peking University First Hospital
Observational
36
Beijing
2026-04-01
Not yet open
Beijing Tongren Hospital
Not applicable
110
Beijing
2026-04-01
By invitation
cRCT of AI Agent in Clinital Resoning Training
NCT07624682Medical Education, Clinical Reasoning, AI Agent
Peking Union Medical College Hospital
Not applicable
88
Beijing
2026-04-01
Recruiting
Shanghai EpimAb Biotherapeutics Co., Ltd.
Phase 1/2
115
Beijing
2026-04-01
Not yet open
Effectiveness and Safety of Acemetacin in Active Axial Spondyloarthritis: A Real-world Study
NCT07582146Axial Spondyloarthritis, Axial Spondyloarthritis, Non-Radiographic, Ankylosing Spondylitis (AS) / Radiographic Axial SpA (r-axSpA)
Chinese PLA General Hospital
Phase 4
150
Beijing
2026-04
Not yet open
Beijing Geekgene Technology Co., LTD
Phase 1
15
Beijing
2026-04
Not yet open
Beijing Union Pharmaceutical Factory Ltd
Phase 1
18
Beijing
2026-04
Not yet open
China-Japan Friendship Hospital
Not applicable
420
Beijing
2026-04
Not yet open
Bachmann Bundle Pacing for Prevention of New-Onset Atrial Fibrillation in Patients With Heart Failure
NCT07547449Heart Failure, Atrial Fibrillation (AF), Cardiac Insufficiency
Fu Wai Hospital, Beijing, China
Not applicable
140
Beijing
2026-04
Not yet open
Nanjing Reju Therapeutics Co., Ltd
Phase 1
42
Beijing
2026-04
Not yet open
Reistone Biopharma Company Limited
Phase 3
600
Beijing
2026-04
Not yet open
Allogeneic vs Autologous PRP for Diabetic Wounds in Renal Dysfunction: a Randomized Controlled Trial
NCT07020559Diabetic Wounds, Platelet Rich Plasma, Allogeneic Blood Transfusions, Renal Dysfunction
Peking University Third Hospital
Phase 4
56
Beijing
2026-04
Not yet open
Angiography-Derived Physiological Indices for Outcome Prediction in Patients Undergoing OCT-Guided PCI
NCT07511231Coronary Artery Disease (CAD) (E.G., Angina, Myocardial Infarction, and Atherosclerotic Heart Disease (ASHD))
Beijing Anzhen Hospital
Observational
1,800
Beijing
2026-04
Not yet open
Burden-Evaluated Active Therapy for AF Using Continuous Wearables BEAT-AF Trial
NCT07512037Atrial Fibrillation (AF), Digital Health Intervention, Wearable Monitoring
Navy General Hospital, Beijing
Not applicable
3,194
Beijing
2026-04
Not yet open
China-Japan Friendship Hospital
Not applicable
285
Beijing
2026-04
Not yet open
Anesthesia Maintenance With Target-controlled Infusion of Propofol and Remifentanil at Fixed Ratio
NCT07479719Elderly, Surgery, Depth of Anesthesia, Total Intravenous Anesthesia
Peking University First Hospital
Phase 4
200
Beijing
2026-04
Recruiting
NK Cell Therapy for Malignant Solid Brain Tumors
NCT07552233Malignant Solid Brain Tumors, Glioblastoma (GBM), Glioblastoma Multiforme (GBM), Brain Metastasis
Peking University Third Hospital
Not applicable
27
Beijing, Qinhuangdao, Zhengzhou
2026-04
Not yet open
Electroacupuncture for the Prevention of Recurrent Lower Urinary Tract Infection in Women
NCT07507851Urinary Tract Infections, Recurrent, Electroacupuncture, Randomized Controlled Trial (RCT)
Yanjun Zhang, Baoyan Liu
Not applicable
312
Beijing, Tianjin
2026-04
Not yet open
Impact of Esketamine on Delayed Neurocognitive Recovery in Older Patients
NCT07523334Elderly, Noncardiac Surgery, Delayed Neurocognitive Recovery, Postoperative Delirium
Peking University First Hospital
Phase 4
120
Beijing, Tanjing
2026-04
Not yet open
Peking University People's Hospital
Not applicable
15
Beijing
2026-04
Not yet open
Peking University First Hospital
Phase 4
274
Beijing
2026-04
Not yet open
Beijing GoBroad Hospital
Observational
50
Beijing
2026-04
Not yet open
Effect of Acupuncture on Psychoneurological Symptom Cluster in Breast Cancer Survivors
NCT07481903Psychoneurological Symptom Cluster(Pain, Insomnia, Anxiety, Fatigue, Depression, Subjective Cognitive Decline), Pain, Insomnia, Anxiety
First Teaching Hospital of Tianjin University of Traditional Chinese Medicine
Not applicable
228
Beijing, Nanjing, Qingdao, Tianjin
2026-04
Not yet open
Peking University First Hospital
Phase 4
274
Beijing
2026-04
Not yet open
Chronic Kidney Disease and Metabolic Disorders in the Elderly
NCT07494526Chronic Kidney Diease, Diabetes Mellitus, Hypertension, Hyperlipidemia
Chinese PLA General Hospital
Observational
100,000
Beijing
2026-04
Not yet open
CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.
Phase 3
900
Beijing
2026-03-31
Not yet open
Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd.
Phase 2
60
Beijing
2026-03-31
Not yet open
Luye Pharma Group Ltd.
Phase 2
160
Beijing
2026-03-31
Recruiting
SinoMab BioScience Ltd
Phase 2
200
Beijing
2026-03-31
Recruiting
Peking University
Not applicable
40
Beijing
2026-03-31
Not yet open
Beijing Tiantan Hospital
Phase 3
636
Beijing
2026-03-31
Not yet open
Beijing Tiantan Hospital
Not applicable
568
Beijing
2026-03-31
Recruiting
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 3
177
Hefei, Beijing, Chongqing, Fuzhou, Lanzhou, Guangzhou, Nanning, Guiyang
2026-03-31
Recruiting
Eisai Co., Ltd.
Phase 2
256
Bengbu, Beijing, Chongqing, Guangzhou, Shantou, Nanning, Guiyang, Luoyang
2026-03-31
Not yet open
Simcere Pharmaceutical Co., Ltd
Phase 2
60
Beijing
2026-03-31
Recruiting
CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.
Phase 3
135
Beijing
2026-03-31
Not yet open
Luye Pharma Group Ltd.
Phase 1/2
99
Beijing
2026-03-31
Active, closed
ChunBao Li
Not applicable
270
Beijing, Shenzhen, Luoyang, Nanjing, Xi'an, Tai’an, Shanghai, Chengdu
2026-03-30
Recruiting
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
Phase 2
30
Beijing
2026-03-30
Recruiting
AstraZeneca
Phase 2
43
Beijing
2026-03-28
Not yet open
Chinese PLA General Hospital
Not applicable
460
Beijing
2026-03-27
Not yet open
Gan & Lee Pharmaceuticals.
Phase 3
140
Beijing
2026-03-27
Not yet open
Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.
Phase 3
912
Beijing
2026-03-27
Recruiting
Chongqing Claruvis Pharmaceutical Co., Ltd.
Phase 3
300
Beijing, Chengdu, Guangdong, Guangzhou, Hefei, Huai'an, Kaifeng, Kunming
2026-03-27
Recruiting
Hypofractionated vs Conventional RT After Prosthetic Breast Reconstruction
NCT07084519Breast Cancer, Breast Reconstruction, Radiation Oncology
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 3
506
Beijing
2026-03-27
Recruiting
Merck Sharp & Dohme LLC
Phase 1/2
60
Hefei, Beijing, Xiamen, Zhengzhou, Xuzhou, Jinan, Hangzhou
2026-03-27
Recruiting
A Study to Assess the Effects of Zigakibart on IgA Nephropathy.
NCT07146906Immunoglobulin A Nephropathy (IgAN)
DrugZigakibart
Novartis Pharmaceuticals
Phase 2
32
Beijing, Shanghai
2026-03-26
Recruiting
Bristol-Myers Squibb
Phase 1/2
474
Beijing, Guangzhou, Tianjin, Harbin, Changsha Shi, Nanjing, Shanghai Shi
2026-03-26
Recruiting
Hangzhou Sumgen Biotech Co., Ltd.
Phase 2
120
Beijing, Chongqing, Xiamen, Lanzhou, Guangzhou, Shenzhen, Guilin, Nanning
2026-03-26
Recruiting
Eisai Inc.
Phase 2
64
Beijing, Changchun, Guangdong, Guangzhou, Jinan, Nanchang, Shanghai, Zhengzhou
2026-03-26
Active, closed
Corregene Biotechnology Co., Ltd
Phase 1
6
Beijing
2026-03-26
Recruiting
Beijing Continent Pharmaceutical Co, Ltd.
Phase 2/3
298
Hefei, Beijing, Fuzhou, Lanzhou, Foshan, Guangzhou, Maoming, Shenzhen
2026-03-26
Recruiting
Oliceridine Versus Sufentanil for Postoperative Nausea in Cerebellopontine Angle Surgery
NCT07479446PONV, Cerebellopontine Angle Tumor, Microvascular Decompression Surgery, Postoperative Analgesia
DrugsOliceridine·Sufentanil
Xuanwu Hospital, Beijing
Not applicable
174
Beijing
2026-03-25
Recruiting
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Phase 2
151
Beijing, Shanghai
2026-03-25
Recruiting
MediLink Therapeutics (Suzhou) Co., Ltd.
Phase 3
440
Anqing, Bengbu, Hefei, Beijing, Chongqing, Fuzhou, Xiamen, Lanzhou
2026-03-24
Recruiting
Novartis Pharmaceuticals
Phase 3
770
Fuzhou, Guangzhou, Wuhan, Changsha, Chengdu, Hangzhou, Beijing, Shanghai
2026-03-24
Recruiting
Shandong Suncadia Medicine Co., Ltd.
Phase 1
168
Beijing, Chongqing
2026-03-24
Recruiting
Lung EIT Image Guide Ventilation in ARDS
NCT07309783ARDS (Acute Respiratory Distress Syndrome)
Peking Union Medical College Hospital
Not applicable
574
Beijing
2026-03-24
Recruiting
Smartwatch-based Intervention for Cardiovascular Health (SWITCH)
NCT07372729Overweight , Obesity, Prediabetes, High-normal Blood Pressure, Borderline Elevated Blood Lipids
Beijing Anzhen Hospital
Not applicable
1,400
Beijing, Cangzhou, Yuhuan
2026-03-24
Recruiting
Boehringer Ingelheim
Phase 2
132
Beijing, Chengdu, Guangzhou, Nanchang, Nanjing, Nanning, Shanghai, Sichuan
2026-03-23
Recruiting
China National Center for Cardiovascular Diseases
Not applicable
40
Beijing
2026-03-23
Recruiting
Amgen
Phase 3
406
Beijing, Zhengzhou, Changsha, Nanjing, Yinchuan, Xi'an, Jinan
2026-03-23
Recruiting
Mitrassist Lifesciences Limited Co., Ltd.
Not applicable
5
Beijing
2026-03-23
Recruiting
Hoffmann-La Roche
Phase 3
1,600
Cangzhou, Kaifeng, Xuzhou, Zhenjiang, Xianyang, Jinan, Ningbo, Beijing
2026-03-23
Recruiting
Beijing Chao Yang Hospital
Not applicable
180
Beijing
2026-03-23
Recruiting
The STEP-MIED Trial: Digital Stepped-Care for Emotional Disorders
NCT07458100Emotional Disorders, Depressive Disorder, Anxiety Disorders, Obsessive-Compulsive Disorder
Peking University
Not applicable
464
Beijing
2026-03-23
Recruiting
Beijing Anzhen Hospital
Not applicable
358
Beijing
2026-03-22
Not yet open
Dermavon Holdings Limited
Phase 2
160
Beijing, Fuzhou, Guangzhou, Shenzhen, Haikou, Shijiazhuang, Tangshan, Zhengzhou
2026-03-20
Recruiting
Radiotherapy After Prostatectomy for Node Positive Prostate Cancer
NCT07477626Prostate Cancer (Post Prostatectomy), Radiotherapy; Image-Guided, Prostate Cancer Non-Metastatic, Androgen Deprivation Therapy
Sun Yat-sen University
Phase 3
372
Dongguan, Guangzhou, Zhanjiang, Zhengzhou, Chengdu, Hangzhou, Beijing, Shanghai
2026-03-20
Recruiting
Peking University
Not applicable
200
Beijing, Baoding, Shijiazhuang, Shenyang, Jinan
2026-03-20
Recruiting
Hutchmed
Phase 3
240
Shanghai, Baoding, Beijing, Bengbu, Changchun, Changsha, Chengdu, Chongqing
2026-03-20
Recruiting
Peking University People's Hospital
Observational
100
Beijing
2026-03-20
Recruiting
Effect of a Localized ICU AI Teaching Agent on Rotating ICU Residents
NCT07692035Cognitive Load and Task Performance in Rotating Residents
Peking Union Medical College Hospital
Not applicable
44
Beijing
2026-03-20
Recruiting
BeOne Medicines
Phase 1
98
Beijing, Chongqing, Fuzhou, Shijiazhuang, Changsha, Suzhou, Shenyang, Shanghai
2026-03-19
Recruiting
Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd.
Phase 2
300
Beijing, Chongqing, Baoding, Cangzhou, Langfang, Shijiazhuang, Zhangjiakou, Zhengzhou
2026-03-19
Recruiting
A Study to Evaluate the Safety and Performance of TruGamma System for Tricuspid Replacement
NCT07691307Tricuspid Valve Regurgitation, Tricuspid Valve Insufficiency, Tricuspid Valve Disease
Jiangsu Trulive Medical Co., Ltd
Not applicable
180
Beijing
2026-03-18
Recruiting
Cadherin 3(CDH3)-Targeted PET in Lung Malignant Tumors
NCT07487883Non-Small Cell Lung Cancer, Malignant Neoplasm, Pulmonary Nodules, PET/CT
Peking University People's Hospital
Observational
80
Beijing
2026-03-18
Recruiting
A Phase II Trial of G01 Eye Drops for Glaucomatous Optic Neuropathy
NCT07777861Primary Open-Angle Glaucoma, Optic Nerve Injury
Qingdao WanMing BioCell Pharmaceutics Co.,Ltd.
Phase 2
90
Beijing, Guangzhou, Shantou, Changsha, Tianjin, Hangzhou, Wenzhou
2026-03-18
Recruiting
Merck Sharp & Dohme LLC
Phase 3
400
Beijing, Chongqing, Fuzhou, Guangzhou, Nanning, Hshijiazhuang, Wuhan, Changsha
2026-03-18
Recruiting
Umbilical Cord Blood CD19-BCMA CART Cell Therapy for SLE-LN, SSc, andpSS PAH.
NCT06947473Refractory Lupus Nephritis, Systemic Sclerosis, Primary Sjogren's Syndrome Combined With Pulmonary Hypertension
Beijing GoBroad Hospital
Phase 1/2
45
Beijing
2026-03-18
Recruiting
Shanghai Mabgen Biopharmaceutical Technology Co., Ltd.
Phase 1
116
Beijing, Chengdu
2026-03-18
Recruiting
Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.
Phase 1
15
Beijing, Suzhou, Jinan, Tianjin, Hangzhou
2026-03-17
Recruiting
HC Biopharma Inc.
Phase 1
331
Beijing
2026-03-17
Recruiting
Beijing Anzhen Hospital
Not applicable
1,312
Beijing, Chengdu, Ürümqi
2026-03-17
Recruiting
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 3
350
Beijing, Shenzhen
2026-03-17
Recruiting
PregnAncy-Related Aortic DISsEction in China
NCT07672210Pregnancy Complication, Aortic Dissection, Marfan Syndrome, Loeys-Dietz Syndrome
DeltaHealth Hospital · Shanghai
Observational
500
Shanghai, Beijing, Guangzhou, Wuhan
2026-03-17
Recruiting
TransThera Sciences (Nanjing), Inc.
Phase 2
94
Guangzhou, Wuhan, Changsha, Nanjing, Jinan, Linyi, Hangzhou, Beijing
2026-03-17
Not yet open
Efficacy and Safety Study of HS-10542 for IgA Nephropathy
NCT07474636IgAN, Immunoglobulin A Nephropathy (IgAN), Glomerular Disease
DrugHS-10542
Jiangsu Hansoh Pharmaceutical Co., Ltd.
Phase 2
90
Beijing
2026-03-17
Recruiting
Hoffmann-La Roche
Phase 3
2,000
Zhenjiang, Xianyang, Jinan, Beijing, Changchun, Hefei, Herbin, Huizhou
2026-03-16
Not yet open
Peking University First Hospital
Not applicable
30
Beijing
2026-03-16
Recruiting
Bristol-Myers Squibb
Phase 3
850
Beijing, Chongqing, Fuzhou, Shantou, Shenzhen, Zhengzhou, Jingzhou, Wuhan
2026-03-16
Not yet open
China National Center for Cardiovascular Diseases
Observational
421
Beijing
2026-03-16
Recruiting
Bristol-Myers Squibb
Phase 1/2
198
Hefei, Beijing, Chongqing, Fuzhou, Guangzhou, Nanning, Harbin, Nanyang
2026-03-16
Not yet open
Peking University Third Hospital
Not applicable
160
Beijing
2026-03-15
Recruiting
Capital Medical University
Not applicable
60
Beijing
2026-03-15
Not yet open
AI-Based Diabetic Foot Recurrence Cohort
NCT07452354Diabetic Foot Ulcer (DFU), Diabete Mellitus, Diabetic Foot Ulcer Treatment, Artificial Intelligence (AI) in Diagnosis
Peking University Third Hospital
Observational
200
Beijing
2026-03-15
Not yet open
A Study of JSKN027 in Patients With Advanced Solid Tumors
NCT07391644Advanced Malignant Solid Tumor
Jiangsu Alphamab Biopharmaceuticals Co., Ltd
Phase 1
250
Beijing
2026-03-15
Recruiting
Beijing GoBroad Hospital
Phase 1
48
Beijing
2026-03-15
Active, closed
Rigerna Therapeutics Co., Ltd.; Rigerna Therapeutics (Beijing) Co., Ltd.
Phase 1
24
Beijing
2026-03-15
Not yet open
Chinese Academy of Medical Sciences, Fuwai Hospital
Phase 4
666
Beijing
2026-03-14
Recruiting
iWAIST Trial: ERCG (Endoscopic Radial Compression Gastroplasty) +Optimized Lifestyle Intervention (OLI) vs Sham + OLI for Weight Loss
NCT07237750Overweight and/or Obesity, Metabolic Syndrome, Nonalcoholic Fatty Liver Disease
Liu Yan
Not applicable
216
Beijing
2026-03-13
Recruiting
Bristol-Myers Squibb
Phase 2/3
690
Beijing, Fuzhou, Guangzhou, Nanning, Harbin, Weihui, Zhengzhou, Wuhan
2026-03-13
Recruiting
Beijing Tiantan Hospital
Not applicable
376
Dongguan, Guangdong, Zhengzhou, Jinan, Jining, Ningbo, Beijing
2026-03-13
Recruiting
Beijing InnoCare Pharma Tech Co., Ltd.
Phase 1
104
Beijing
2026-03-13
Recruiting
Sanofi
Phase 2/3
526
Beijing, Chengdu, Guangzhou, Hangzhou, Jinan, Nanchang, Nanning, Shanghai
2026-03-13
Active, closed
Sanofi
Phase 3
59
Baotou, Beijing, Chengdu, Jinan, Jingzhou, Nanning, Shenyang, Taiyuan
2026-03-12
Recruiting
Bristol-Myers Squibb
Phase 3
750
Beijing, Fuzhou, Xiamen, Zhangzhou, Guangzhou, Shantou, Nanning, Harbin
2026-03-12
Recruiting
Peking Union Medical College Hospital
Observational
1,380
Beijing
2026-03-12
Recruiting
Low-dose Colchicine for Thromboprophylaxis After Transcatheter Aortic Valve Replacement
NCT07411768Transcatheter Aortic Valve Replacement, Transcatheter Heart Valve Thrombosis, Anti-inflammatory Therapy
DrugColchicine
China National Center for Cardiovascular Diseases
Not applicable
116
Beijing
2026-03-12
Recruiting
Astellas Pharma Global Development, Inc.
Phase 2
240
Shanghai, Chengdu, Beijing, Langfang
2026-03-12
Recruiting
Takeda
Phase 3
1,182
Bengbu, Beijing, Guangzhou, Wuhan, Zhuzhou, Baotou Shi, Pingxiang, Linyi Shi
2026-03-11
Recruiting
Pfizer
Phase 1/2
132
Beijing, Nanjing, Tianjin, Ningbo
2026-03-11
Recruiting
Phase II Trial of RC1416 Injection in Asthma
NCT07403487Moderate to Severe Asthma
DrugRC1416
Nanjing RegeneCore Biotech Co., Ltd.
Phase 2
195
Anqing, Suzhou, Beijing, Chongqing, Lanzhou, Shijiazhuang, Tangshan, Xingtai
2026-03-10
Recruiting
Aortic No-Touch vs Partial Aortic Clamping in Off-Pump CABG
NCT07302659Coronary Artery Bypass Graft (CABG)
China National Center for Cardiovascular Diseases
Not applicable
380
Beijing, Qingdao, Shenzhen
2026-03-10
Recruiting
Novel Calcium Channel Modulators in RLS and Variants: Efficacy & Safety
NCT07453862Restless Leg Syndrome (RLS), Variant Restless Legs Syndrome
DrugCrisugabalin
Beijing Friendship Hospital
Phase 1
20
Beijing
2026-03-10
Recruiting
Beijing Tiantan Hospital
Not applicable
318
Beijing
2026-03-10
Recruiting
Beijing Youcare Kechuang Pharmaceutical Technology Co., Ltd.
Phase 1
76
Beijing
2026-03-10
Recruiting
Beijing Tiantan Hospital
Not applicable
110
Beijing
2026-03-10
Recruiting
Beijing Tiantan Hospital
Not applicable
190
Beijing
2026-03-10
Recruiting
Novartis Pharmaceuticals
Phase 2
210
Guangzhou, Wuhan, Beijing, Shanghai
2026-03-09
Recruiting
Jemincare
Phase 3
240
Beijing
2026-03-09
Not yet open
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.
Phase 3
380
Beijing
2026-03-09
Recruiting
Eli Lilly and Company
Phase 4
150
Beijing, Changsha, Guangdong, Guangzhou, Lanzhou, Nanchang, Shanghai, Taizhou
2026-03-09
Recruiting
Perioperative Multimodal Analgesia for Supratentorial Craniotomy
NCT07441421Postoperative Pain, Analgesia, Supratentorial Brain Tumor
DrugDexmedetomidine
Beijing Tiantan Hospital
Not applicable
2,000
Beijing
2026-03-09
Recruiting
Baricitinib for Post-HSCT Persistent Thrombocytopenia
NCT07535645Persistent Thrombocytopenia, Allogeneic Hematopoietic Stem Cell Transplantation
DrugBaricitinib
Peking University People's Hospital
Phase 1/2
28
Beijing
2026-03-09
Recruiting
Base Therapeutics (Shanghai) Co., Ltd.
Early Phase 1
18
Beijing
2026-03-09
Not yet open
Gan & Lee Pharmaceuticals.
Phase 1
198
Beijing
2026-03-09
Recruiting
CAS for Stenosis With High-risk Features for CEA
NCT07370246Carotid Artery Stenosis, Carotid Artery Stenting
Beijing Tiantan Hospital
Not applicable
212
Beijing, Chongqing, Nanning, Guiyang, Shijiazhuang, Xingtai, Wuhan, Hohhot
2026-03-06
Recruiting
AstraZeneca
Observational
2,100
Beijing, Changsha, Chengdu, Guangzhou, Haerbin, Jinan, Nantong, Shanghai
2026-03-06
Recruiting
CompaRison of FEmorofemoral Bypass and Left-Heart ByPass Techniques in Open Thoracoabdominal AortIc Aneurysm Repair
NCT07518251Thoracoabdominal Aortic Aneurysm, Cardiopulmonary Bypass, Open Repair
Beijing Anzhen Hospital
Not applicable
236
Beijing
2026-03-06
Recruiting
Haisco Pharmaceutical Group Co., Ltd.
Phase 1
159
Beijing
2026-03-06
Recruiting
Janssen Research & Development, LLC
Phase 3
600
Beijing, Changsha, Cheng Du Shi, Dongguan, Guangzhou, Hangzhou, Hefei, Jinhua
2026-03-05
Recruiting
Peking University People's Hospital
Phase 1/2
56
Beijing
2026-03-05
Recruiting
ART Trial: Transcatheter J-VALVE Versus Surgery for Aortic Regurgitation Therapy
NCT07453407Aortic Regurgitation, Aortic Valve Insufficiency, Aortic Insufficiency
Second Affiliated Hospital, Zhejiang University, School of Medicine
Not applicable
1,250
Hefei, Beijing, Fuzhou, Guangzhou, Zhengzhou, Hong Kong, Wuhan, Changsha
2026-03-05
Recruiting
Guangzhou Lupeng Pharmaceutical Company LTD.
Phase 1
28
Beijing
2026-03-05
Recruiting
A Phase I Clinical Trial to Evaluate CMS-D017 Following Single and Multiple Doses in Healthy Participants
NCT07462780Paroxysmal Nocturnal Hemoglobinuria, PNH, Complement-mediated Kidney Disease
Shenzhen Kangzhe Biotechnology Co., Ltd.
Phase 1
88
Beijing
2026-03-05
Not yet open
Clinical Study of IM96 CAR-T Cell Therapy in Patients With Advanced Adenocarcinoma of Gastric/Esophagogastric Junction
NCT07406984Adenocarcinoma of Gastric, Adenocarcinoma of Esophagogastric Junction
Beijing Immunochina Medical Science & Technology Co., Ltd.
Phase 1
18
Beijing
2026-03-05
Not yet open
Heilongjiang Feihe Dairy Co. Ltd.
Not applicable
124
Beijing, Foshan, Zhuhai, Xiangtan, Wuxi, Chengdu
2026-03-05
Recruiting
Incyte Corporation
Phase 3
700
Beijing, Changsha, Chengdu, Chongqing, Foshan, Fuzhou, Guangzhou, Hangzhou
2026-03-05
Recruiting
A Study of TPD3310 in Patients With Advanced Malignant Tumors
NCT07368127Advanced Malignant Solid Tumors
TAIBIDI PHARMACEUTICAL TECHNOLOGY(SHIJIAZHUANG) CO.,LTD.
Phase 1
112
Beijing
2026-03-05
Recruiting
SKB105 for Injection in Advanced Solid Tumors
NCT07380386Advanced Solid Tumors
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
Phase 1/2
256
Beijing, Shanghai
2026-03-05
By invitation
Suzhou Immunofoco Biotechnology Co., Ltd
Phase 1/2
30
Beijing
2026-03-05
Recruiting
Peking University People's Hospital
Not applicable
30
Beijing
2026-03-04
Recruiting
Peking University People's Hospital
Not applicable
200
Beijing
2026-03-03
Recruiting
A Study of DXC014 in Patients With Advanced Solid Tumors.
NCT07177937Small Cell Lung Cancer, Melanoma, Prostate Cancer, Other Advanced Solid Tumors
Hangzhou DAC Biotechnology Co., Ltd.
Phase 1
150
Beijing, Changsha, Nanchang, Qingdao, Hangzhou
2026-03-03
Recruiting
Shanghai Ark Biopharmaceutical Co., Ltd.
Phase 2/3
290
Beijing, Guangzhou, Cangzhou, Nanyang, Zhengzhou, Wuhan, Hangzhou, Rui’an
2026-03-03
Recruiting
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 1
55
Beijing
2026-03-03
Recruiting
Shanghai Longwood Biopharmaceuticals Co., Ltd.
Phase 3
480
Beijing
2026-03-03
Not yet open
Akeso
Phase 2
111
Beijing
2026-03-02
Recruiting
Beijing Tiantan Hospital
Not applicable
156
Beijing
2026-03-02
Recruiting
Zai Lab (Shanghai) Co., Ltd.
Phase 1
180
Beijing, Shanghai
2026-03-02
By invitation
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Observational
4,000
Beijing
2026-03-02
Recruiting
Beijing Tiantan Hospital
Not applicable
134
Beijing
2026-03-02
Not yet open
Advenchen Laboratories Nanjing Ltd.
Phase 1
16
Beijing
2026-03-02
Recruiting
Bambusa Therapeutics
Phase 1/2
64
Beijing, Guangzhou, Changsha, Nanjing, Jinan, Qingdao, Yantai, Zibo
2026-03-02
Recruiting
The Efficacy and Safety of Liposomal Bupivacaine in Relieving Postoperative Pain After Video-assisted Thoracoscopic Surgery
NCT07432711Video-assisted Thoracoscopic Surgery (VATS), Pain Management, Liposomal Bupivacaine, Local Injection
DrugsBupivacaine Hydrochloride·Liposomal bupivacaine·Bupivacaine
Beijing Tiantan Hospital
Not applicable
100
Beijing
2026-03-02
Not yet open
Xuanwu Hospital, Beijing
Observational
2,000
Beijing
2026-03-01
Recruiting
Tianjin Medical University Cancer Institute and Hospital
Phase 2
49
Beijing, Wuhan, Chengdu, Tianjin
2026-03-01
Not yet open
Peking University Third Hospital
Not applicable
100
Beijing
2026-03-01
Not yet open
Peking Union Medical College Hospital
Not applicable
200
Beijing
2026-03-01
Recruiting
Guang'anmen Hospital of China Academy of Chinese Medical Sciences
Not applicable
100
Beijing
2026-03-01
Recruiting
Chinese PLA General Hospital
Phase 2
120
Beijing
2026-03-01
Not yet open
Peking University Third Hospital
Observational
120
Beijing
2026-03-01
Not yet open
TAVR for Aortic Regurgitation Under TEE Guidance
NCT07453849Aortic Regurgitation, Transcatheter Aortic Valve Replacement
Chinese Academy of Medical Sciences, Fuwai Hospital
Not applicable
30
Beijing
2026-03-01
Not yet open
The Efficacy and Safety of Endovascular Treatment for Acute Mild Basilar Artery Occlusion
NCT07390032Acute Mild Basilar Artery Occlusion, Basilar Artery Occlusion, Endovascular Treatment
Feng Gao
Not applicable
230
Beijing
2026-03-01
Recruiting
Beijing Friendship Hospital
Not applicable
186
Beijing
2026-03-01
Recruiting
Orelabrutinib in the Treatment of Relapsed/Refractory AIHA
NCT07453368Autoimmune Hemolytic Anemia (AIHA)
Peking Union Medical College Hospital
Phase 2
50
Beijing
2026-03-01
Recruiting
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Observational
250
Beijing
2026-03-01
Active, closed
Effect of Central Venous Catheterization on Brain Pressure in Acute Brain Injury Patients
NCT07704528Acute Brain Injury, Traumatic Brain Injury, Intracerebral Hemorrhage, Aneurysmal Subarachnoid Hemorrhage (aSAH)
Beijing Tiantan Hospital
Observational
120
Beijing, Guiyang
2026-03-01
Recruiting
Comparison of TB+PB and TB+6SB for Prostate Cancer Diagnosis
NCT07460843Prostate Cancer (Diagnosis)
Peking University First Hospital
Not applicable
592
Beijing
2026-03-01
Recruiting
Discovery and Validation of Biomarkers for CSA-AKI Risk Prediction
NCT07811570CSA-AKI, Acute Kidney Injury, Cardiovascular Surgery, Biomarkers
China National Center for Cardiovascular Diseases
Observational
1,500
Beijing
2026-03-01
Recruiting
West China Hospital
Observational
200
Beijing, Xuzhou, Chengdu
2026-03-01
Not yet open
IFN-α in Relapse Prevention.
NCT07449286Acute Myeloid Leukemia, Myelodysplastic Syndromes
DrugIFN-α
Peking University People's Hospital
Phase 2
100
Beijing
2026-03-01
Not yet open
Shanghai Escugen Biotechnology Co., Ltd
Phase 2
40
Beijing, Xiamen, Guilin, Langfang, Changde, Changsha, Zhuzhou, Xuzhou
2026-03-01
Active, closed
Vincentage Pharma Co., Ltd
Phase 2
160
Beijing
2026-03-01
Active, closed
China-Japan Friendship Hospital
Not applicable
469
Beijing
2026-03-01
Not yet open
Chinese PLA General Hospital
Phase 1
25
Beijing
2026-03-01
Not yet open
China National Center for Cardiovascular Diseases
Observational
820
Beijing
2026-03-01
Recruiting
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 2
184
Beijing
2026-03-01
Not yet open
Short-Course Radiotherapy Combined With Chemotherapy and Immunotherapy in Mid-Low Locally Advanced Rectal Cancer
NCT07397442Rectal Cancer, Adenocarcinoma, Rectal Cancer Stage II, Rectal Cancer Stage III
Beijing Friendship Hospital
Phase 2
19
Beijing
2026-03-01
Not yet open
Tsinghua University
Observational
30
Beijing
2026-03
Not yet open
Emergency Stroke Unit With NeuAngio-CT (ESU-ACT)
NCT07456228Acute Ischemic Stroke
Beijing Tiantan Hospital
Observational
500
Beijing
2026-03
Not yet open
Peking University Cancer Hospital & Institute
Phase 2
76
Beijing
2026-03
Not yet open
Peking University
Phase 1
66
Beijing
2026-03
Not yet open
Sir Run Run Shaw Hospital
Not applicable
206
Bengbu, Beijing, Nanning, Haikou, Zhengzhou, Zhoukou, Chenzhou, Huai'an
2026-03
Not yet open
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.
Phase 3
142
Hefei, Beijing, Chongqing, Fuzhou, Xiamen, Lanzhou, Guangzhou, Meizhou
2026-03
Not yet open
Beijing Union Pharmaceutical Factory Ltd
Phase 1
24
Beijing
2026-03
Not yet open
Chengdu Kangnuoxing Biopharma,Inc.
Observational
400
Beijing
2026-03
Recruiting
A Retrospective Real-World Study Based on RATIONALE-307
NCT07478809NSCLC (Advanced Non-small Cell Lung Cancer)
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Observational
109
Beijing
2026-02-28
Active, closed
Ribotek Biopharmaceuticals (Shandong) Co., Ltd
Phase 2
40
Daqing, Harbin, Luoyang, Jingzhou, Nanyang, Yuncheng, Beijing
2026-02-28
Not yet open
Chinese PLA General Hospital
Not applicable
232
Beijing
2026-02-28
Not yet open
Tanhuo Decoction for Acute Coronary Syndrome With Cerebral Atherosclerosis in Elderly Patients
NCT07445581Acute Coronary Syndrome Comorbid With Cerebral Atherosclerosis
Jinggang Xia, MD
Not applicable
480
Beijing
2026-02-28
Recruiting
InxMed (Shanghai) Co., Ltd.
Phase 1/2
92
Beijing, Fuzhou, Guangzhou, Zhengzhou, Luoyang, Changsha, Nanjing, Shengyang
2026-02-28
Not yet open
Chinese PLA General Hospital
Not applicable
270
Beijing
2026-02-28
Recruiting
CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.
Phase 3
760
Beijing
2026-02-28
Recruiting
Antengene Biologics Limited
Phase 1/2
132
Hefei, Beijing, Fuzhou, Xiamen, Lanzhou, Langfang, Shijiazhuang, Anyang
2026-02-27
Recruiting
Shanghai Henlius Biotech
Phase 2/3
706
Beijing
2026-02-27
Recruiting
Hangzhou Huasai Biomedicine Co., Ltd.
Phase 2
90
Beijing
2026-02-26
Recruiting
Nanjing Leads Biolabs Co.,Ltd
Phase 2
110
Beijing, Anyang, Luoyang, Zhengzhou, Jinan, Suining
2026-02-26
Recruiting
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 1/2
465
Beijing, Chongqing, Guangzhou, Guanzhou, Zhongshan, Nanning, Cangzhou, Harbin
2026-02-26
Recruiting
Beijing Anzhen Hospital
Not applicable
252
Beijing, Dalian, Jilin City, Nanchang, Shanghai
2026-02-26
Recruiting
Beijing Anzhen Hospital
Not applicable
564
Beijing, Changchun, Dalian, Nanchang, Shanghai
2026-02-25
Recruiting
Study on the Efficacy and Safety of Mecobalamin in Preventing Taxane-related Peripheral Neuropathy
NCT07423390Peripheral Neuropathy Due to Chemotherapy, Peripheral Neuropathy, Chemotherapy-induced
DrugMecobalamin
Qinghai Red Cross Hospital
Phase 3
326
Xining, Jinan, Beijing
2026-02-24
Recruiting
Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.
Phase 3
240
Beijing
2026-02-24
Recruiting
AstraZeneca
Phase 3
508
Beijing, Changchun, Changsha, Chongqing, Guangzhou, Hefei, Nanchang, Nanjing
2026-02-23
Recruiting
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 1
9
Beijing
2026-02-20
Recruiting
A Clinical Study of MK-1045 in People With Lupus or Rheumatoid Arthritis (MK-1045-004)
NCT07363590Systemic Lupus Erythematosus, Rheumatoid Arthritis
DrugMK-1045
Merck Sharp & Dohme LLC
Phase 1
21
Beijing, Luoyang, Wuhan, Shanghai
2026-02-19
Recruiting
Shenzhen Kangzhe Biotechnology Co., Ltd.
Phase 2
120
Beijing
2026-02-19
Recruiting
Boehringer Ingelheim
Phase 3
1,325
Anyang, Baoji, Baotou, Beijing, Cangzhou, Changchun, Changsha, Chengdu
2026-02-17
By invitation
LI FENG
Not applicable
308
Beijing
2026-02-17
Recruiting
Boehringer Ingelheim
Phase 3
286
Baotou, Beijing, Changchun, Changsha, Chengdu, Guangzhou, Hangzhou, Lanzhou
2026-02-16
Recruiting
EIT-Guided Respiratory Physiotherapy for Prolonged Mechanical Ventilation (PMV)
NCT07372794Prolonged Mechanical Ventilation, Respiratory Failure, Critical Illness
Capital Medical University
Not applicable
200
Beijing
2026-02-16
Not yet open
Chemotherapy With or Without Adebrelimab and T-DXh as Neoadjuvant Therapy for HR+/HER2 Low Early Stage Breast Cancer
NCT07317778Breast Cancer Early Stage Breast Cancer (Stage 1-3), HR Positive/HER2 Low Breast Cancer
DrugsTrastuzumab Rezetecan·Adebrelimab
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 2
249
Beijing
2026-02-15
Recruiting
Beijing Friendship Hospital
Observational
60
Beijing
2026-02-15
Recruiting
Peking University Third Hospital
Not applicable
44
Beijing
2026-02-14
Recruiting
Clinical Study of XNW5004 Tablets in the Treatment of Relapsed and Refractory Follicular Lymphoma
NCT07545603Follicular Lymphoma, Grade 1, Follicular Lymphoma, Grade 2, Follicular Lymphoma, Grade 3, Follicular Lymphoma Grade 3A
DrugMevrometostat
Evopoint Biosciences Inc.
Phase 2
65
Beijing
2026-02-14
Recruiting
Beijing InnoCare Pharma Tech Co., Ltd.
Phase 2/3
344
Bengbu, Wuhu, Beijing, Chongqing, Fuzhou, Guangzhou, Shijiazhuang, Luoyang
2026-02-13
Recruiting
Peking University People's Hospital
Not applicable
31
Beijing
2026-02-13
Not yet open
Preoperative Hypofractionated RT + Immunotherapy & Surgery for Retroperitoneal Sarcoma (FUSION-02)
NCT07396116Soft Tissue Sarcoma (STS), Retroperitoneal Sarcoma, Immunotherapy, Radiotherapy Side Effect
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Not applicable
28
Beijing
2026-02-12
Recruiting
A Trial of SHR-A2102 With Adebrelimab in Locally Advanced or Metastatic Urothelial Carcinoma
NCT07393542Locally Advanced or Metastatic Urothelial Carcinoma
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Phase 3
453
Beijing
2026-02-12
Not yet open
Beijing Tongren Hospital
Not applicable
206
Beijing
2026-02-12
Not yet open
Beijing Tongren Hospital
Not applicable
128
Beijing
2026-02-12
Recruiting
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 1/2
105
Hefei, Beijing, Fuzhou, Lanzhou, Shantou, Nanning, Guangxi, Zunyi
2026-02-12
Not yet open
Shenzhen Kexing Pharmaceutical Co., Ltd.
Phase 1
48
Beijing, Guiyang, Zhengzhou, Nanchang, Hangzhou
2026-02-12
Recruiting
Pfizer
Phase 2/3
1,156
Chizhou, Fuyang, Hefei, Beijing, Chongqing, Guangzhou, Huizhou, Xinxiang
2026-02-11
Recruiting
I-Mab Biopharma US Limited
Phase 2
180
Beijing
2026-02-11
Recruiting
Peking University People's Hospital
Phase 2
39
Beijing, Xi'an
2026-02-10
Recruiting
Innovent Biopharmaceutical Technology (Hangzhou) Co., LTD.
Phase 3
540
Beijing
2026-02-10
Recruiting
Eli Lilly and Company
Phase 3
800
Beijing, Changchun, Changsha, Chengdu, Chongqing, Guangzhou, Hefei, Kunming
2026-02-10
Recruiting
NWRD09 for Persistent Cervical HPV16 Infection
NCT07710703Persistent Cervical HPV16 Infection
Newish Biotech (Wuxi) Co., Ltd.
Not applicable
60
Beijing
2026-02-10
Recruiting
Neoadjuvant Chemoradiotherapy Plus Tislelizumab With or Without Probio-M9 in pMMR/MSS Locally Advanced Rectal Cancer
NCT07458529Rectal Cancer, Adenocarcinoma, Neoadjuvant Therapy, Immunotherapy, Probio-M9
Seventh Medical Center of PLA General Hospital
Phase 2
50
Beijing
2026-02-10
Not yet open
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 2
78
Beijing
2026-02-10
Recruiting
Pfizer
Phase 1/2
224
Beijing, Chongqing, Wuhan, Changsha, Nanjing, Jinan, Ningbo
2026-02-10
Not yet open
Individualized Open Lung Ventilation and Postoperative Pulmonary Complications in Thoracic Surgery
NCT07387822Postoperative Pulmonary Complications (PPCs), One-lung Ventilation (OLV), Thoracic Surgery, Video Assisted
Aerospace Center Hospital
Not applicable
352
Beijing
2026-02-10
Recruiting
Eli Lilly and Company
Phase 3
1,000
Beijing, Changsha, Chaohu, Chengdu, Guangzhou, Haidian District, Hefei, Huzhou
2026-02-09
Recruiting
Hangzhou Sciwind Biosciences Co., Ltd.
Phase 3
140
Beijing
2026-02-09
Recruiting
Safety and Efficacy of Cryoablation for Thyroid Tumors
NCT07776262Thyroid Tumor, Thyroid Neoplasm
Yukun Luo
Not applicable
108
Beijing
2026-02-09
Recruiting
Eli Lilly and Company
Phase 3
900
Beijing, Bengbu, Changchun, Changsha, Chongqing, Hangzhou, Hefei, Jinan
2026-02-09
Active, closed
Janssen Research & Development, LLC
Phase 2
168
Beijing, Chaoyang District, Guangzhou, Shanghai
2026-02-08
Recruiting
Beijing Tiantan Hospital
Not applicable
568
Beijing, Longzhou, Luoyang, Panlong, Changle
2026-02-08
Recruiting
Peking University First Hospital
Observational
300
Beijing
2026-02-08
Recruiting
Eli Lilly and Company
Phase 3
1,980
Beijing, Chengdu, Guangzhou, Hefei, Jinan, Luoyang Shi, Nanchang, Nanjing
2026-02-06
Recruiting
Innovent Biologics (Suzhou) Co. Ltd.
Phase 2
120
Beijing
2026-02-06
Recruiting
A Dose-exploration Study of EDP167 in HoFH
NCT07489209Homozygous Familial Hypercholesterolemia (HoFH)
DrugEDP167
Eddingpharm (Zhuhai) Co., Ltd.
Phase 2
20
Beijing
2026-02-06
Recruiting
Guangzhou Lupeng Pharmaceutical Company LTD.
Phase 3
394
Beijing, Nanning
2026-02-05
Recruiting
Beijing Mabworks Biotech Co., Ltd.
Phase 1/2
130
Beijing
2026-02-05
Active, closed
Innovent Biologics (Suzhou) Co. Ltd.
Phase 2
352
Beijing
2026-02-05
Not yet open
IBI363 as Neoadjuvant Therapy in Resectable Stage II-III Non-Small Cell Lung Cancer
NCT07402070Resectable Stage II-III Non-small Cell Lung Cancer
DrugLenvatinib
Innovent Biologics (Suzhou) Co. Ltd.
Phase 2
10
Beijing
2026-02-04
Active, closed
Predicting Pathological Complete Response in Rectal Cancer Using Machine Learning
NCT07509632Rectal Cancers, Pathological Complete Response, Neoadjuvant Chemoradiotherapy, Machine Learning
Peking University People's Hospital
Observational
320
Beijing
2026-02-04
Recruiting
Eli Lilly and Company
Phase 1
68
Beijing, Changsha, Hefei, Shanghai, Wenzhou, Wuhan
2026-02-04
Recruiting
Beijing Inno Medicine Co., Ltd.
Phase 2
40
Beijing
2026-02-04
Recruiting
Janssen Research & Development, LLC
Phase 3
400
Beijing, Chengdu, Guangzhou, Hangzhou, Nanjing, Nanning, Shanghai, Wenzhou
2026-02-04
Recruiting
Peking Union Medical College Hospital
Early Phase 1
6
Beijing
2026-02-03
Recruiting
AstraZeneca
Phase 3
2,130
Beijing, Changde, Chengdu, Chongqing, Fuzhou, Guangzhou, Hangzhou, Harbin
2026-02-03
Recruiting
Arch-Clamping Technique Under Mild Hypothermia in Treating With Acute Type A Aortic Dissection
NCT07150559Acute Type A Aortic Dissection, Hypothermia, Total Aortic Arch Replacement, Frozen Elephant Trunk
Beijing Anzhen Hospital
Not applicable
306
Beijing
2026-02-03
Recruiting
Bristol-Myers Squibb
Phase 1/2
240
Beijing, Shanghai
2026-02-03
Recruiting
Capital Medical University
Not applicable
2,400
Beijing
2026-02-02
Recruiting
Shanghai Yidian Pharmaceutical Technology Development Co., Ltd.
Phase 2
309
Beijing
2026-02-02
Not yet open
Longbio Pharma
Phase 2
46
Beijing
2026-02-02
Recruiting
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Observational
30
Beijing
2026-02-01
By invitation
Clinical Efficacy of Exoskeleton Robot-Assisted Rehabilitation on Lower Limb Functional Recovery in Elderly Patients With Hip Fracture
NCT07323147Hip Fracture, Geriatrics, Lower Extremity Dysfunction, Postoperative Rehabilitation
Hai bao
Not applicable
86
Beijing
2026-02-01
Not yet open
Zhijie Wang
Phase 2
28
Beijing
2026-02-01
Recruiting
5T MRI and Metabolomics-Based Hemorrhage Risk Prediction in Moyamoya Disease
NCT07781579Moyamoya Disease, Intracranial Hemorrhages, Stroke
Beijing Hospital
Observational
500
Beijing
2026-02-01
Recruiting
Biomarker-Guided Allogeneic Single-Target or Dual-Target CAR-NK Cell Therapy for Advanced Solid Tumors
NCT07410494Cancer, Breast Cancer, Non-Small Cell Lung Cancer (NSCLC), Colorectal Cancer (Locally Advanced or Metastatic)
DrugsAldesleukin·Fludarabine·Cyclophosphamide
Essen Biotech
Phase 1/2
85
Beijing
2026-02-01
Not yet open
Peking Union Medical College Hospital
Not applicable
358
Beijing, Huai'an, Jiangxi, Kunshan
2026-02-01
By invitation
Hongying Jiang, MD
Observational
184
Beijing
2026-02-01
Recruiting
EBNK-001 Allogeneic NK Cells With Low-Dose IL-15 ± Pembrolizumab in Advanced Solid Tumors
NCT07410676Cancer, Sarcoma, Leukaemia, Breast Cancer (Locally Advanced or Metastatic)
DrugPembrolizumab
Essen Biotech
Phase 1/2
83
Beijing
2026-02-01
Recruiting
Therapy in the Acute Phase of NMOSD: A Multicenter Prospective Real-World Study
NCT07410039Neuromyelitis Optica Spectrum Disorder Attack
DrugsIVMP·Eculizumab·IVIG
Chinese PLA General Hospital
Phase 4
200
Beijing
2026-02-01
Recruiting
Chinese PLA General Hospital
Phase 2
44
Beijing
2026-02-01
Not yet open
Perioperative Tamsulosin for Treating Voiding Dysfunction Following Prostate Biopsy
NCT07276919Acute Urinary Retention, LUTS(Lower Urinary Tract Symptoms)
DrugTamsulosin
Peking University First Hospital
Phase 4
1,844
Beijing
2026-02-01
Not yet open
Portal Vein Thrombosis in Cirrhosis: Incidence, Outcomes and Anticoagulation
NCT07422701Portal Vein Thrombosis, Liver Cirrhosis
Peking University First Hospital
Observational
2,522
Beijing, Shenzhen, Hengshui, Qinhuangdao, Wuxi, Qingdao
2026-02-01
Not yet open
Objective Vascular Biomarkers as Triage for Depression in Chronic Atrophic Gastritis
NCT07319338Chronic Atrophic Gastritis, Depressive Symptoms, Depression, Gastrointestinal Diseases
China Academy of Chinese Medical Sciences
Observational
520
Beijing, Hengshui, Changzhou
2026-02-01
Not yet open
Proactive Temperature Management in CRS-HIPEC for Prevention of Delirium
NCT07378371Pseudomyxoma Peritonei, Postoperative Delirium (POD)
Aerospace Center Hospital
Not applicable
174
Beijing
2026-02-01
Recruiting
Peking University Third Hospital
Observational
40
Beijing
2026-02-01
Not yet open
Peking University Third Hospital
Not applicable
240
Beijing
2026-02-01
Not yet open
The Efficacy and Safety of Microbiota Transplantation Combined With Prebiotics for Treatment of Functional Constipation
NCT07386795Constipation - Functional, Chronic Constipation, Fecal Microbiota Transplantation
Peking Union Medical College Hospital
Not applicable
19
Beijing
2026-02-01
Not yet open
Peking Union Medical College Hospital
Not applicable
30
Beijing
2026-02-01
By invitation
Hongying Jiang, MD
Not applicable
280
Beijing
2026-02-01
Not yet open
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 3
3,142
Beijing
2026-02-01
Recruiting
Clinical Investigator-Initiated Trial (IIT) of PD-L1-Targeted Radionuclide Probes
NCT07848243Lung Cancer (NSCLC), Cervical Squamous Cell Cancer, Melanoma (Skin Cancer), Breast Cancer
DrugFluorodeoxyglucose
Peking University Cancer Hospital & Institute
Phase 2
50
Beijing
2026-02-01
Not yet open
Peking University Third Hospital
Phase 2
40
Beijing
2026-02
Recruiting
Beijing Balance Medical Technology Co., Ltd
Not applicable
800
Beijing
2026-02
Recruiting
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 2
157
Beijing
2026-02
Not yet open
ImmuneOnco Biopharmaceuticals (Shanghai) Inc.
Phase 3
198
Beijing
2026-02
Recruiting
Beijing GoBroad Hospital
Phase 1
18
Beijing
2026-02
Not yet open
MindRank AI Ltd
Phase 3
738
Beijing, Changchun, Changde, Changsha, Datong, Dongyang, Ganzhou, Hefei
2026-02
Not yet open
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Early Phase 1
20
Beijing
2026-01-31
Not yet open
Peking University Cancer Hospital & Institute
Phase 2
44
Beijing
2026-01-31
Recruiting
Basilar Artery Occlusion Chinese Endovascular Registry in Patients With Large-Core Infarct
NCT07345702Basilar Artery Occlusion, Ischemic Stroke, Large Core Infarct
Xuanwu Hospital, Beijing
Observational
518
Beijing
2026-01-31
Not yet open
Jingyi Ge
Observational
120
Beijing
2026-01-31
Recruiting
Zorifertinib With Osimertinib for NSCLC With Meningeal Progression
NCT07361705Patients With Advanced Non-small Cell Lung Cancer With Meningeal Progression After Osimertinib Treatment
DrugOsimertinib
Alpha Biopharma (Jiangsu) Co., Ltd.
Phase 1
42
Beijing, Shengyang, Guangzhou, Henan, Shanxi
2026-01-31
Not yet open
Qian geng
Observational
800
Beijing
2026-01-31
Not yet open
AI-Generated Video Feedback to Improve Technical Skills in Coronary Artery Bypass Grafting
NCT07400172Cardiac, Surgery (Cardiac), Education, Artificial Intelligence (AI)
China National Center for Cardiovascular Diseases
Not applicable
100
Beijing
2026-01-31
Recruiting
Betta Pharmaceuticals Co., Ltd.
Phase 1/2
164
Beijing
2026-01-31
Not yet open
Aiyoudong Children and Youth Sports Health Research Institute
Not applicable
100
Beijing
2026-01-30
Recruiting
Xuanwu Hospital, Beijing
Phase 4
72
Beijing
2026-01-30
Recruiting
Intrauterine Injection of Type III Collage in FST of EC/AEH
NCT07377734Atypical Endometrial Hyperplasia, Endometrial Cancer
DrugProgestin
Wang Jianliu
Phase 2
30
Beijing
2026-01-30
Recruiting
Beijing Tiantan Hospital
Phase 3
436
Beijing
2026-01-30
Not yet open
Beijing Tiantan Hospital
Not applicable
164
Beijing
2026-01-30
Recruiting
Symbiotic-Lung-20: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Different Anticancer Agents in Advanced Cancers
NCT07227298Advanced/Metastatic Non-Small Cell Lung Cancer, Carcinoma, Non-Small Cell Lung, Non-Small Cell Lung Cancer
DrugsSigvotatug vedotin·PF-08634404
Pfizer
Phase 1/2
162
Beijing, Fuzhou, Wuhan, Nanjing, Shanghai, Taizhou
2026-01-30
Recruiting
Genmab
Phase 2
240
Shanghai, Beijing, Changchun, Nanjing, Tianjin, Zhangjiakou, Zhengzhou
2026-01-30
Not yet open
Isa-VRD in TIE HRMM
NCT07334535Multiple Myeloma
Peking Union Medical College Hospital
Phase 4
117
Beijing
2026-01-30
Recruiting
Merck Sharp & Dohme LLC
Phase 1/2
170
Beijing, Fuzhou, Guangzhou, Jiangmen, Harbin, Nanchang, Shanghai, Chengdu
2026-01-29
Recruiting
Dizal Pharmaceuticals
Phase 1/2
203
Beijing
2026-01-29
Recruiting
Fulzerasib Sequential Sintilimab Plus Platinum-Doublet Neoadjuvant Therapy for Resectable KRAS G12C-Mutant NSCLC
NCT07492342Resectable NSCLC, KRAS G12C Mutation, Stage IB-IIIA NSCLC, Neoadjuvant Therapy
DrugsFulzerasib·Sintilimab
Jianxing He
Phase 2
30
Beijing, Guangzhou, Zhejiang
2026-01-29
Active, closed
HS-20093 in Patients With Advanced Gastric and Gastroesophageal Junction Adenocarcinoma
NCT07462923Advanced Gastric and Gastroesophageal Junction Adenocarcinoma
DrugRis-Rez
Hansoh BioMedical R&D Company
Phase 1
40
Beijing, Fuzhou, Xiamen, Shijiazhuang, Harbin, Zhengzhou, Wuhan, Changsha
2026-01-29
Recruiting
Shenzhen Majory Biotechnology Co., Ltd.
Phase 1/2
42
Beijing, Hubei, Hunan
2026-01-29
Recruiting
Hope Medicine (Nanjing) Co., Ltd
Phase 3
540
Beijing, Nanning, Suzhu, Shanghai, Tianjin
2026-01-29
Recruiting
AstraZeneca
Phase 3
400
Beijing, Binzhou, Changsha, Chengdu, Chongqing, Deyang, Fuzhou, Guangzhou
2026-01-28
Recruiting
Lanzhou University Second Hospital
Not applicable
706
Beijing, Lanzhou, Shijiazhuang
2026-01-27
Not yet open
Preventing Neurologic Complications in Valve Surgery
NCT07382362Left Atrial Appendage Closure
China National Center for Cardiovascular Diseases
Observational
100
Beijing, Qingdao, Shenzhen
2026-01-27
Not yet open
Efficacy and Safety of Qibei Jiedu Formula for Preventing and Managing Acute Radiation Dermatitis in Breast Cancer Patients
NCT07380230Acute Radiation Dermatitis, Traditional Chinese Medicine (TCM), Breast Cancer
LI FENG
Not applicable
60
Beijing
2026-01-27
Active, closed
Time-Restricted Eating for Weight-Loss Maintenance
NCT07163455Overweight or Obese Adults
Harbin Medical University
Not applicable
500
Beijing, Chongqing, Shenzhen, Harbin, Xi'an, Qingdao, Weifang, Chengdu
2026-01-26
Active, closed
Takeda
Phase 2
91
Beijing, Guangzhou, Wuhan, Shanghai, Hangzhou
2026-01-26
Recruiting
Shanghai JMT-Bio Inc.
Phase 1
44
Beijing
2026-01-26
Recruiting
Sichuan Purity Pharmaceutical Technology Co., Ltd.
Phase 2
456
Beijing
2026-01-26
Recruiting
Lenvatinib Plus Chemotherapy for pNET Liver Metastases
NCT07835893Pancreatic Neuroendocrine Tumor With Liver Metastases
DrugLenvatinib
Peking Union Medical College Hospital
Phase 2
80
Beijing
2026-01-26
Not yet open
Peking University Aerospace Center Hospital
Observational
1,500
Beijing
2026-01-25
Recruiting
Rehabilitation Exercise Against Complications in High-risk Elderly After Lumbar Fusion(REACH)
NCT07396051Adjacent Segment Degeneration, Multimodal Rehabilitation, Lumber Fusion
Xuanwu Hospital, Beijing
Not applicable
212
Beijing
2026-01-25
By invitation
Vaginal Function Exercisers and Vaginal Dilation Irrigation Drug Administration Tubes Are Used for Vaginal Rehabilitation Therapy in Pelvic Radiotherapy
NCT07473271Indicated for Pelvic Radiotherapy, Vaginal Rehabilitation, and Alleviation of Late Toxic Reactions in the Vagina
Peking Union Medical College Hospital
Not applicable
76
Beijing
2026-01-23
Recruiting
Peking University Third Hospital
Not applicable
72
Beijing
2026-01-23
Recruiting
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 1
86
Beijing, Fuzhou, Meizhou, Shanghai, Chengdu
2026-01-22
Recruiting
Intra-arterial Tenecteplase for Acute Medium Vessel Occlusion Stroke
NCT07357987Ischemic Stroke, Medium Vessel Occlusion, Tenecteplase, Endovascular Treatment
Beijing Tiantan Hospital
Phase 3
488
Beijing
2026-01-22
Recruiting
BeOne Medicines
Phase 3
500
Beijing, Chongqing, Fuzhou, Guangzhou, Nanning, Guiyang, Harbin, Zhengzhou
2026-01-22
Recruiting
Gan & Lee Pharmaceuticals.
Phase 3
500
Beijing
2026-01-22
Recruiting
Peking University First Hospital
Phase 2/3
90
Beijing
2026-01-21
Recruiting
Hoffmann-La Roche
Observational
500
Xiamen, Lanzhou, Shijiazhuang, Changchun, Wenzhou, Beijing, Chengdu, Chongqing
2026-01-21
Recruiting
Peking University Cancer Hospital & Institute
Phase 1
24
Beijing
2026-01-20
By invitation
Peking Union Medical College Hospital
Observational
100
Beijing
2026-01-20
Recruiting
Xiamen Amoytop Biotech Co., Ltd.
Phase 3
141
Beijing, Changchun, Changsha, Chengdu, Chongqing, Fuzhou, Guangzhou, Haikou
2026-01-20
Recruiting
DualityBio Inc.
Phase 1/2
127
Beijing
2026-01-20
Not yet open
Longbio Pharma
Phase 2
150
Beijing
2026-01-20
Active, closed
Janssen Research & Development, LLC
Phase 2
189
Beijing, Changsha, Chengde, Chengdu, Guangzhou, Sanmenxia, Wuxi, Xi'an
2026-01-20
Recruiting
A Study to Evaluate the Safety and Drug Levels of ASP5541 in Chinese Participants With Prostate Cancer
NCT07339267Prostate Cancer, Metastatic Castration-Resistant Prostate Cancer, Metastatic Hormone Sensitive Prostate Cancer
DrugsPRL-02·Prednisone
Astellas Pharma Global Development, Inc.
Phase 1
12
Beijing
2026-01-20
Active, closed
Peking Union Medical College Hospital
Observational
1,000
Beijing
2026-01-20
Recruiting
Xuanwu Hospital, Beijing
Phase 4
316
Beijing
2026-01-20
Recruiting
China-Japan Friendship Hospital
Observational
790
Beijing
2026-01-19
Recruiting
China-Japan Friendship Hospital
Observational
210
Beijing
2026-01-19
Recruiting
Inspiratory Effort-Targeted Pressure Support Ventilation (IT-PSV) Trial
NCT06526598Critical Care, Acute Hypoxic Respiratory Failure, Ventilator-Induced Lung Injury
Capital Medical University
Not applicable
619
Beijing
2026-01-19
Active, closed
A Phase II Trial of SHR-3045 Injection in Patients With Rheumatoid Arthritis
NCT07233655Moderate to Severe Active Rheumatoid Arthritis
Guangdong Hengrui Pharmaceutical Co., Ltd
Phase 2
30
Beijing
2026-01-19
Not yet open
Chinese PLA General Hospital
Not applicable
218
Beijing
2026-01-17
Recruiting
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 2
46
Beijing
2026-01-16
Recruiting
Boehringer Ingelheim
Phase 3
400
Beijing, Changchun, Changsha, Chengdu, Guangzhou, Hangzhou, Harbin, Jinan
2026-01-16
Recruiting
Sanofi
Phase 3
751
Guangzhou, Huizhou, Wuxi, Chengdu, Beijing, Hefei, Kunming, Shanghai
2026-01-16
Active, closed
Beijing QL Biopharmaceutical Co.,Ltd
Phase 3
755
Xuancheng, Beijing, Chongqing, Lanzhou, Guangzhou, Huizhou, Nanning, Handan
2026-01-16
Not yet open
Xuanwu Hospital, Beijing
Not applicable
65
Beijing
2026-01-15
Recruiting
BioNTech SE
Phase 2
75
Beijing, Chongqing, Jinan, Shanghai, Shenzhen, Wuhan
2026-01-15
Not yet open
Wangjing Hospital, China Academy of Chinese Medical Sciences
Not applicable
106
Beijing, Changsha, Tianjin
2026-01-15
Not yet open
Xuanwu Hospital, Beijing
Not applicable
160
Beijing
2026-01-15
Active, closed
Janssen Research & Development, LLC
Phase 2
157
Beijing, Changsha, Changzhou, Chengdu, Chongqing, Hangzhou, Ningbo, Shanghai
2026-01-15
Recruiting
InnovStone Therapeutics Limited
Phase 1
112
Beijing
2026-01-15
Recruiting
Bristol-Myers Squibb
Observational
500
Beijing, Guangzhou, Jiazhuang, Zhengzhou, Suzhou, Changchun, Dalian, Xi'an
2026-01-15
Recruiting
Prediction Model for MINS After Major Hepatobiliary Surgery
NCT07335042Myocardial Injury After Noncardiac Surgery (MINS), Postoperative Complications, Liver Neoplasm, Hepatobiliary Diseases
Beijing Tsinghua Chang Gung Hospital
Observational
1,800
Beijing, Chongqing, Qingdao, Shandong, Zhuhai
2026-01-14
Recruiting
Sanofi
Phase 3
160
Beijing, Chengdu, Dongguan, Guangzhou, Jiazhuang, Shenyang
2026-01-14
Active, closed
Viatris Pharmaceuticals Co., Ltd.
Phase 2
15
Guangzhou, Shijiazhuang, Luoyang, Zhengzhou, Jiujiang, Nanchang, Beijing
2026-01-14
Active, closed
Fujian Shengdi Pharmaceutical Co., Ltd.
Phase 2
238
Beijing
2026-01-14
Recruiting
Innostellar Biotherapeutics Co.,Ltd
Phase 3
388
Hefei, Beijing, Chongqing, Guangzhou, Shantou, Zhongshan, Xingtai, Harbin
2026-01-14
Recruiting
A Phase I Study of JLM019 Injection
NCT07623850Advanced Solid Tumor (Phase 1), Hodgkin Lymphoma, Non-Hodgkin Lymphoma
Jecho Biopharmaceuticals Co., Ltd.
Phase 1
115
Beijing
2026-01-13
Recruiting
RemeGen Co., Ltd.
Phase 3
120
Beijing
2026-01-13
Recruiting
A Phase I Trial of A-CAR032 in Participants With mCRPC
NCT07344311Prostate Cancer, Metastatic Castration-Resistant Prostate Cancer
Shanghai AbelZeta Ltd.
Phase 1
27
Beijing, Wuhan, Xuzhou, Hangzhou
2026-01-13
By invitation
Xiangya Hospital of Central South University
Observational
1,500
Beijing, Guangzhou, Jinan, Shanghai
2026-01-13
Not yet open
Beijing Tiantan Hospital
Phase 3
564
Beijing
2026-01-12
Recruiting
RemeGen Co., Ltd.
Phase 3
555
Beijing
2026-01-12
Recruiting
Sichuan Baili Pharmaceutical Co., Ltd.
Phase 1
33
Beijing
2026-01-12
Recruiting
Capital Medical University
Observational
1,300
Beijing
2026-01-10
Recruiting
Peking University People's Hospital
Not applicable
40
Beijing
2026-01-10
Not yet open
Institute of Hematology & Blood Diseases Hospital, China
Early Phase 1
38
Zhengzhou, Wuhan, Xuzhou, Nanchang, Beijing, Tianjin
2026-01-10
Recruiting
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Early Phase 1
36
Beijing
2026-01-10
Not yet open
Osteoporotic Vertebral Compression Fracture Cohort Study
NCT07321795OVCF Database, Cohort Study
Wangjing Hospital, China Academy of Chinese Medical Sciences
Observational
200
Hunan, Suzhou, Weihai, Beijing
2026-01-10
Active, closed
Peking University People's Hospital
Phase 2
42
Beijing
2026-01-10
Not yet open
China-Japan Friendship Hospital
Early Phase 1
60
Beijing
2026-01-10
Active, closed
LishitonglinUS-01 Trial
NCT07769060Urethra Stricture
Peking University First Hospital
Phase 2
120
Beijing
2026-01-09
Recruiting
Shanghai Hengrui Pharmaceutical Co., Ltd.
Phase 1/2
60
Beijing
2026-01-08
Recruiting
Shanghai SciBrunch Therapeutics Co., Ltd.
Phase 1/2
210
Hefei, Beijing, Guangzhou, Harbin, Zhengzhou, Wuhan, Xuzhou, Shenyang
2026-01-08
Recruiting
Sinocelltech Ltd.
Phase 3
90
Beijing
2026-01-08
Recruiting
Novo Nordisk A/S
Phase 3
460
Beijing, Zhengzhou, Wuhan, Changchun, Jinan, Shanghai, Chengdu
2026-01-08
Recruiting
Xin Lou
Observational
200
Beijing
2026-01-07
Recruiting
Photon-counting CT for Intracranial Stent Assessment
NCT07769814Intracranial Atherosclerotic Disease (ICAD), Intracranial Arterial Stenosis, Stent Restenosis, Ischemic Stroke
Xin Lou
Observational
200
Beijing
2026-01-07
Recruiting
Photon-Counting CT Versus Conventional CT for Carotid Plaque Assessment in Patients With Carotid Artery Stenosis
NCT07762664Carotid Artery Stenosis, Carotid Atherosclerosis, Carotid Atherosclerotic Plaque
Chinese PLA General Hospital
Observational
100
Beijing
2026-01-07
Recruiting
Beijing Tiantan Hospital
Phase 4
440
Beijing
2026-01-07
Recruiting
Photon-Counting Cardiac CT in Post-PCI Patients
NCT07763340Cardiovascular Diseases
Chinese PLA General Hospital
Observational
800
Beijing
2026-01-07
Recruiting
Peking University People's Hospital
Early Phase 1
18
Beijing
2026-01-07
Recruiting
Beijing Tiantan Hospital
Not applicable
280
Beijing
2026-01-06
Recruiting
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
NCT07222566Advanced Non-Small Cell Lung Cancer, Non-Small Cell Lung Cancer, Carcinoma, Non-Small-Cell Lung, Carcinoma, Non-Small-Cell Lung (NSCLC)
DrugsPF-08634404·Pembrolizumab
Pfizer
Phase 3
1,410
Hefei, Beijing, Chongqing, Fuzhou, Guangzhou, Huizhou, Jiangmen, Nanning
2026-01-06
Recruiting
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Phase 1/2
92
Beijing
2026-01-06
Recruiting
Tenecteplase Before Interhospital Transfer for EVT in Acute Anterior Circulation LVO at 4.5-24 Hours
NCT07253181Acute Ischemic Stroke, Large Vessel Occlusion, Transportation of Patients
DrugsTenecteplase (TNK)·Maximum
Xuanwu Hospital, Beijing
Phase 3
572
Beijing, Weifang
2026-01-06
Recruiting
Peking University First Hospital
Phase 4
316
Beijing
2026-01-05
Recruiting
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 1/2
29
Beijing
2026-01-05
Recruiting
A Phase I/III Clinical Study to Evaluate NouvNeu001 Injection for Multiple System Atrophy
NCT07289477Multiple System Atrophy - Parkinsonian Subtype (MSA-P)
iRegene Therapeutics Co., Ltd.
Phase 1
9
Beijing
2026-01-05
Recruiting
A Clinical Trial of P134 Cells in Recurrent Glioblastoma
NCT07318818Recurrent Glioblastoma IDH Wildtype
Tasly Pharmaceutical Group Co., Ltd
Phase 1/2
26
Beijing
2026-01-05
Recruiting
3H Pharmaceuticals Co., Ltd.
Phase 1/2
170
Beijing
2026-01-04
Recruiting
Peking Union Medical College Hospital
Not applicable
30
Beijing
2026-01-03
Recruiting
Beijing Tsinghua Chang Gung Hospital
Observational
275
Beijing, Chenzhou, Loudi
2026-01-02
Recruiting
Bristol-Myers Squibb
Phase 2/3
590
Hefei, Beijing, Chongqing, Fuzhou, Xiamen, Guangzhou, Shenzhen, Nanning
2026-01-02
Not yet open
Critical Illness After Hematopoietic Cell Transplantation
NCT07328724Critical Illness, Ventilated Patients, Hematopoetic Stem Cell Transplantation, Transplant Complication
Peking University People's Hospital
Observational
4,000
Beijing, Chongqing, Hangzhou, Harbin, Tianjin, Wuhan
2026-01-01
Recruiting
SGLT2 Inhibitors on Coronary Atherosclerosis Progression Via Perivascular Adipose Tissue in Diabetes
NCT07614230Type 2 Diabetes Mellitus (T2DM), Coronary Artery Disease, Atherosclerosis
DrugDapagliflozin
Junjie Yang
Phase 4
144
Beijing
2026-01-01
Active, closed
Clinically Actionable Tumor-Associated Antigens in Prostate Cancer
NCT07597369Prostate Cancer, Metastatic Prostate Cancer, Metastatic Prostate Cancer (mCRPC)
Peking University First Hospital
Observational
1,600
Beijing
2026-01-01
Active, closed
Chinese PLA General Hospital
Observational
94
Beijing
2026-01-01
Not yet open
Beijing Children's Hospital
Not applicable
2,650
Beijing, Chongqing, Guangzhou, Baoding, Zhengzhou, Wuxi, Changchun, Xi'an
2026-01-01
Not yet open
Coronary Imaging and Metabolic Indicators-Based Risk Prediction Model for Coronary Artery Disease(CMI-RiskCAD)
NCT07353762Coronary Artery Disease (CAD) (E.G., Angina, Myocardial Infarction, and Atherosclerotic Heart Disease (ASHD))
Beijing Anzhen Hospital
Observational
10,960
Beijing
2026-01-01
Recruiting
Acepodia Biotech, Inc.
Phase 1/2
34
Beijing, Chengdu, Hangzhou, Hefei, Shanghai, Taiyuan, Wuhan
2026-01-01
Recruiting
Ademetionine in Obstructive Hypertrophic Cardiomyopathy
NCT07367724Obstructive Hypertrophic Cardiomyopathy (oHCM)
DrugTransmeti
China National Center for Cardiovascular Diseases
Phase 2
44
Beijing, Shanghai, Xinjiang
2026-01-01
Recruiting
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Observational
900
Beijing
2026-01-01
Recruiting
Beijing Chest Hospital, Capital Medical University
Observational
500
Beijing
2026-01-01
Not yet open
Second Affiliated Hospital, Zhejiang University, School of Medicine
Not applicable
848
Beijing, Huangshi, Wuhan, Xiangyang, Hangzhou, Jiaxing, Ningbo
2026-01-01
Active, closed
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 2
40
Beijing
2026-01-01
Active, closed
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Observational
300
Beijing
2026-01-01
Not yet open
Lin Zhao
Not applicable
162
Beijing
2026-01-01
Recruiting
SHAOYAN LIU
Phase 1
12
Beijing
2026-01-01
Not yet open
Peking University Third Hospital
Observational
290
Beijing
2026-01-01
Not yet open
Peking Union Medical College Hospital
Early Phase 1
15
Beijing, Mianyang
2026-01-01
Recruiting
Yan Fuxia
Observational
144
Beijing
2026-01-01
Active, closed
Treatment Outcomes for Osteochondritis Dissecans of the Knee: A Cohort Study
NCT07439107Osteochondritis Dissecans Knee, Osteochondritis Dissecans (OCD)
Peking University Third Hospital
Observational
254
Beijing
2026-01-01
Recruiting
A Study of Chiglitazar in Patients With Metabolic Dysfunction-associated Steatohepatitis and Type 2 Diabetes Mellitus
NCT07303803MASH - Metabolic Dysfunction-Associated Steatohepatitis, T2DM (Type 2 Diabetes Mellitus)
DrugsChiglitazar·Vitamin E
Shanghai Jiao Tong University School of Medicine
Phase 2
300
Beijing, Chongqing, Fuzhou, Guangzhou, Wuhan, Shiyan, Changsha, Changchun
2026-01-01
Recruiting
Peking University People's Hospital
Early Phase 1
132
Beijing
2026-01-01
Recruiting
Peking University People's Hospital
Observational
4,800
Beijing
2026-01-01
Active, closed
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Observational
60
Beijing
2026-01-01
Not yet open
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Phase 4
174
Beijing, Foshan, Harbin, Zhengzhou, Wuhan, Nanjing, Nanchang, Jilin City
2026-01-01
Recruiting
Xuanwu Hospital, Beijing
Observational
600
Beijing
2026-01-01
Not yet open
China-Japan Friendship Hospital
Observational
284
Beijing
2026-01-01
Not yet open
The Efficacy and Safety of Endovascular Therapy for Acute Ischemic Stroke Due to Large Core Infarction
NCT07333950Acute Basilar Artery Occlusion, Endovascular Therapy, Large Core Infarction
Beijing Tiantan Hospital
Not applicable
308
Beijing
2026-01-01
Not yet open
Urinary Function and Multimorbidity Risks: A Longitudinal Study in Beijing Community-Dwelling Elderly
NCT07357714Chronic Kidney Disease, Overactive Bladder, Benign Prostatic Hyperplasia, Female Pelvic Floor Dysfunction
Chinese PLA General Hospital
Observational
500
Beijing
2026-01-01
Not yet open
Peking Union Medical College Hospital
Phase 3
348
Beijing
2026-01-01
Not yet open
Hongying Jiang, MD
Not applicable
500
Beijing, Hunan, Guangxi, Jilin City, Henan
2026-01-01
Active, closed
Prediction Model for Postoperative Headache After Transsphenoidal Pituitary Surgery
NCT07446036Headache, Pituitary Adenoma, Endonasal Surgery, Predictive Model
Beijing Tiantan Hospital
Observational
500
Beijing
2026-01-01
By invitation
Immune Evaluation for Postoperative Sepsis-AKI
NCT07811544Sepsis, Acute Kidney Injury
Beijing Chao Yang Hospital
Observational
800
Beijing
2026-01-01
Recruiting
Qing Yuan
Not applicable
5
Beijing
2026-01-01
Recruiting
Geriatric Assessment (GA) for Elderly Patients Undergoing Allo-HSCT
NCT06946654Elderly, Geriatric Assessment, ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION
Peking University People's Hospital
Observational
176
Beijing
2026-01-01
Not yet open
Comprehensive Care of Sleep Disordered Breathing
NCT07339371Sleep Disordered Breathing (SDB)
Beijing Anzhen Hospital
Observational
11,100
Beijing
2026-01-01
Recruiting
Targeted CD22/CD19 CAR-T Therapy for Consolidation in Standard-Risk B-ALL
NCT07575919B-cell Acute Lymphoblastic Leukemia
Liping Dou
Phase 1/2
20
Beijing
2026-01-01
Recruiting
Cardiovascular Outcomes and Risk Evaluation Among Recipients of Hematopoietic Stem Cell Transplantation
NCT07349498Hematopoietic Stem Cell Transplantation, Transplant Complication, Cardiovascular Events
Peking University People's Hospital
Observational
10,000
Beijing, Chongqing, Guangzhou, Shenzhen, Harbin, Zhengzhou, Wuhan, Xi'an
2026-01-01
Recruiting
Xiaohui Ren
Observational
300
Beijing
2026-01-01
By invitation
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Observational
354
Beijing
2026-01-01
Recruiting
Heronova Pharmaceuticals
Phase 1
76
Beijing
2026-01-01
Recruiting
Peking University People's Hospital
Not applicable
307
Beijing
2026-01-01
Not yet open
AI Wound Alert & Home Management for Recurrent DFU
NCT07277010Diabetic Foot Ulcer (DFU)
Peking University Third Hospital
Observational
200
Beijing
2026-01-01
Not yet open
Multimodal Exercise Therapy for Non-Surgical Intervention of Nonspecific Low Back Pain.
NCT07353372Paraspinal Muscles, Low Back Pain, Machine Learning, Radiomics
DrugNSAIDs
Xuanwu Hospital, Beijing
Not applicable
314
Beijing
2026-01-01
Recruiting
Cardiac Magnetic Resonance - PROgnostic HEart Scar for Sudden Cardiac Death Prediction StudY
NCT07137936Sudden Death, Cardiac, Myocardial Scarring, Myocardial Infarction (MI)
Beijing Anzhen Hospital
Observational
1,000
Beijing
2026-01-01
Recruiting
Beijing Shijitan Hospital, Capital Medical University
Observational
49
Beijing, Haidian
2026-01-01
Recruiting
Liping Dou
Phase 2
20
Beijing
2026-01-01
By invitation
Beijing Chest Hospital
Phase 2
24
Beijing
2026-01-01
Recruiting
Liping Dou
Phase 1/2
30
Beijing
2026-01-01
Recruiting
Golidocitinib Combined With Selinexor for CAEBVD
NCT07369739Lymphohistiocytosis, EBV, CAEBV
DrugsGolidocitinib·Selinexor
Beijing Friendship Hospital
Phase 2/3
28
Beijing
2026-01-01
Recruiting
Ablation Compare With Surgery for Early Breast Cancer
NCT07484087Breast Cancer, Early Stage, Hormone Receptor Positive, Ablation
Peking University People's Hospital
Not applicable
264
Beijing
2026-01-01
Not yet open
Guangzhou University of Traditional Chinese Medicine
Observational
3,000
Beijing, Guangzhou, Weihui, Shanghai, Chengdu
2026-01
Not yet open
KN5501 Cell Injection for Refractory SLE(CLEAR)
NCT07358988Systemic Lupus Erthematosus (SLE)
Ruitherapeutics Co., LTD
Phase 1
36
Bengbu, Beijing, Luoyang, Wuhan, Nanjing, Shanghai
2026-01
Not yet open
Peking University First Hospital
Phase 2
40
Beijing
2026-01
Not yet open
Beijing Anzhen Hospital
Not applicable
792
Beijing, Dalian, Jilin City
2026-01
Not yet open
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 2
292
Beijing
2025-12-31
Not yet open
Jemincare
Phase 3
472
Beijing
2025-12-31
Recruiting
Tasly Pharmaceutical Group Co., Ltd
Phase 1/2
54
Beijing
2025-12-31
Recruiting
Fujian Shengdi Pharmaceutical Co., Ltd.
Phase 2
153
Beijing
2025-12-31
Active, closed
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 2
9
Beijing
2025-12-31
Not yet open
Peking University People's Hospital
Observational
159
Beijing
2025-12-30
Rows per page Showing 1001–1500 of 5576
Previous 1 2 3 4 5 Next
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 9 November 2026. https://priyalifescience.com/clinical-trials-china/city/beijing?page=3

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,187 studies in total at the last sync on 08 Nov 2026, 03:17 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 5,576 of those studies with a site in Beijing.

How many clinical trials are recruiting in Beijing?

3,389 of the 5,576 studies on this page are recruiting new participants as of the 08 Nov 2026, 03:17 UTC sync. A further 990 have not yet opened recruitment, 1,019 are active but closed to new participants, and 178 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.